Literature DB >> 17079433

Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska Native population.

Karen M Miernyk1, Dana L Bruden, Michael G Bruce, Brian J McMahon, Thomas W Hennessy, Helen V Peters, Debby A Hurlburt, Frank Sacco, Alan J Parkinson.   

Abstract

Helicobacter pylori antibodies were measured over 24 months in American Indian and Alaska Native persons who cleared their infections. Two months after treatment, 82% of H. pylori-negative persons remained seropositive. While there were declines in H. pylori antibodies for 12 months, after 24 months 71% of persons remained seropositive.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17079433      PMCID： PMC1797704          DOI： 10.1128/CVI.00253-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  10 in total

1.  Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan.

Authors:  M Kato; Y Yamaoka; J J Kim; R Reddy; M Asaka; K Kashima; M S Osato; F A El-Zaatari; D Y Graham; D H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Chronological change in H. pylori antibody titers after treatment and its utility in follow-up.

Authors:  Kate Vikram; N Ananthakrishnan; S Badrinath
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

3.  Utility of serology in determining Helicobacter pylori eradication after therapy.

Authors:  C A Fallone; V G Loo; A N Barkun
Journal:  Can J Gastroenterol       Date:  1998-03       Impact factor: 3.522

4.  Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.

Authors:  J J Kim; R Reddy; M Lee; J G Kim; F A El-Zaatari; M S Osato; D Y Graham; D H Kwon
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

5.  Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection.

Authors:  G I Pérez-Pérez; A F Cutler; M J Blaser
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University.

Authors:  A Vasquez; Y Valdez; R H Gilman; J J McDonald; T U Westblom; D Berg; H Mayta; V Gutierrez
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

7.  Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.

Authors:  B J McMahon; M G Bruce; T W Hennessy; D L Bruden; F Sacco; H Peters; D A Hurlburt; J M Morris; A L Reasonover; G Dailide; D E Berg; A J Parkinson
Journal:  Aliment Pharmacol Ther       Date:  2006-04-15       Impact factor: 8.171

8.  Four-year trends in Helicobacter pylori IgG serology following successful eradication.

Authors:  A F Cutler; V M Prasad; P Santogade
Journal:  Am J Med       Date:  1998-07       Impact factor: 4.965

9.  A sensitive and specific serologic test for detection of Campylobacter pylori infection.

Authors:  D J Evans; D G Evans; D Y Graham; P D Klein
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

10.  Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.

Authors:  Wasaburo Koizumi; Satoshi Tanabe; Hiroshi Imaizumi; Ken-ichi Hibi; Mitsuhiro Kida; Masahito Ohida; Isao Okayasu; Katsunori Saigenji
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb
  10 in total
  7 in total

1.  Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.

Authors:  Dana L Bruden; Michael G Bruce; Karen M Miernyk; Julie Morris; Debby Hurlburt; Thomas W Hennessy; Helen Peters; Frank Sacco; Alan J Parkinson; Brian J McMahon
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

Review 2.  The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary.

Authors:  B J McMahon; M G Bruce; A Koch; K J Goodman; V Tsukanov; G Mulvad; M L Borresen; F Sacco; D Barrett; S Westby; A J Parkinson
Journal:  Epidemiol Infect       Date:  2015-06-22       Impact factor: 2.451

3.  H. pylori-associated pathologic findings among Alaska native patients.

Authors:  Leisha Diane Nolen; Dana Bruden; Karen Miernyk; Brian J McMahon; Frank Sacco; Wayne Varner; Tom Mezzetti; Debby Hurlburt; James Tiesinga; Michael G Bruce
Journal:  Int J Circumpolar Health       Date:  2018-12       Impact factor: 1.228

4.  Declining prevalence of Helicobacter pylori infection in Jordanian children, report from developing country.

Authors:  Eyad Altamimi; Noor Alsharkhat; Afnan AlJawarneh; Moh D Rawhi Abu Hamad; Anas Abu Assi; Sarah Alawneh; Majd Al-Ahmad
Journal:  Heliyon       Date:  2020-07-20

5.  The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population.

Authors:  Ying-Ying Yu; Jian-Ting Cai; Zhen-Ya Song; Yu-Ling Tong; Jing-Hua Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  A Case Control Study of the Seroprevalence of Helicobacter pylori Proteins and Their Association with Pancreatic Cancer Risk.

Authors:  Jennifer B Permuth; Shams Rahman; Dung-Tsa Chen; Tim Waterboer; Anna R Giuliano
Journal:  J Pancreat Cancer       Date:  2021-09-16

7.  Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?

Authors:  Sabine Skrebinska; Francis Megraud; Ilva Daugule; Daiga Santare; Sergejs Isajevs; Inta Liepniece-Karele; Inga Bogdanova; Dace Rudzite; Reinis Vangravs; Ilze Kikuste; Aigars Vanags; Ivars Tolmanis; Selga Savcenko; Chloé Alix; Rolando Herrero; Jin Young Park; Marcis Leja
Journal:  Diagnostics (Basel)       Date:  2022-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.